A bacteriophage, VP882, has been identified to use bacterial quorum-sensing as a method to control the lysis-lysogeny decision. This is the first time a virus has been shown to detect a bacterial molecule.
Researchers have successfully used monoclonal antibodies to protect animal models from Candida infections for the first time, demonstrating their potential for treating this fungal disease.
More focus should be put on determining if pathogens are resistant or resilient to antibiotics, according to a new study. This distinction could allow for improved, personalized treatment and help to preserve current antibiotics.
Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
A WHO report has indicated that measles cases spiked globally due to gaps in vaccination coverage, as many countries experienced severe outbreaks.
New research has suggested that the spread of prions to the brain does not occur via the blood–brain barrier, implicating other mechanisms.
Declining HIV diagnoses in the UK have been highlighted in a recent report from Public Health England, meaning that for the first time UN targets have been reached.
Researchers have developed a freeze-dried polio vaccine that doesn’t require refrigeration and is still efficacious after rehydration.
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.